Risk MAPS - the Most Extensive Hereditary Cancer Risk Assessment Test — Protean BioDx
shutterstock_1090856084.jpg
Screen Shot 2023-03-15 at 3.18.15 PM.png
Screen Shot 2021-09-03 at 1.51.10 PM.png
Screen+Shot+2023-02-17+at+3.51.43+PM.jpg
Screen Shot 2022-01-18 at 1.36.03 PM.png

Nanostics and Protean launch CDX Prostate for men at risk of developing aggressive prostate cancer

 

The number of genes known to be involved in hereditary cancer syndromes and risk is steadily increasing. Genetic testing is recommended for the proper treatment of many cancers.

  • The information provided by hereditary genetic testing determines risk of cancer, and guides therapy.
  • Protean offers the most extensive testing panel available to ensure that genes are not missed.
  • We produce a simplified analysis report with guidance for the busy practitioner.
  • If needed, we can arrange for genetic counseling and informed consent for testing.
  • The data is protected for future use if new genes are identified.
 
 
 
 
 
 

Choice of Test

The practitioner can select a focused gene panel for a particular disease site, limiting the number of genes analyzed. Protean also offers a comprehensive panel that includes all of the currently known genes associated with hereditary cancer risk.

 
 
 
 
 
 

How is the Test Done?

  • The test is performed on a cheek swab sample.

  • Samples can be collected in the doctor’s office or at the patient’s home.

  • DNA samples take 2-3 weeks to be sequenced and analyzed.

  • Informed consent should be completed prior to sample collection, and when the results are delivered.

 
 
 

Contact us now to order or receive more information.

 Have questions? Contact us today.

Phone: +1 (754) 242 9682 | Email: info@proteanbiodx.com